Last reviewed · How we verify
NCT06126211
Reliability And Validity Of The Usage Of The Camry Dynamometer In Healthy Adults
trial testing Assessment in Hand Grasp in 78 participants. Completed in 13 December 2023.
4 December 2023
Quick facts
| Lead sponsor | sena ozdemir |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 78 |
| Start date | 20 November 2023 |
| Primary completion | 4 December 2023 |
| Estimated completion | 13 December 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Assessment
Conditions studied
- Hand Grasp — all drugs for Hand Grasp →
Sponsor
sena ozdemir
Who can join
18 and older, any sex, with Hand Grasp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Jamar hydraulic hand dynamometer, is a high cost and manual device that is commonly used for the evaluation of the hand grip strength (HGS) with validity and reliability. Nowadays it is thought that usage of the digital and automatic calibration dynamometers, such as Camry, would be more appropriate in the evaluation of the HGS. This research is a cross-sectional study using the random crossover method. Purpose of the study is comparing the outcome measures of the Camry and Jamar dynamometers in healthy adult individuals and investigating the realiability and validity of the Camry usage. Healthy adult male and female individuals aged 18 and over will be included in the study on a voluntary basis. Power analysis was performed to determine the number of people to be included in the study. The power of the test was calculated with the G\*Power 3.1 program and was determined as 60 participants. Inclusion criteria of the study; Healthy adults aged 18 and over, individuals who do not have any restrictions in upper extremity functions and do not have cognitive and/or psychological problems will be included. Individuals under 18 years of age, using an assistive device, having an autoimmune disorder, pregnant individuals, and individuals with a history of hospitalization for more than three days in the last six months will not be included in the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06126211
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Assessment
Trials testing the same drug.
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07225920 — Understanding Needs of Older Patients Prior to Starting Cancer Treatment · NA · enrolling by invitation
- NCT07249541 — Hypermobility, Foot Posture, and Scoliosis Severity · not yet recruiting
- NCT07256873 — Validity and Reliability of Face-to-Face and Tele-Assessment of Core Stability and Functional Capacity · completed
- NCT07249515 — Scapula and Upper Extremity Performance in Scoliosis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06126211 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by sena ozdemir
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126211.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing